Skip to content

Matrix Matters: Yolk-Driven Effects for Exercise Recovery

Matrix Matters: Yolk-Driven effects on muscle soreness for Exercise Recovery among regularly active participants

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000759392
Enrollment
22
Registered
2026-06-25
Start date
2027-02-01
Completion date
2027-11-02
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Randomised 3×3 crossover; each participant completes three fasted morning visits with unilateral EIMD (limb alternation; adequate washouts). Post-exercise breakfast (within 30–45 min): whole eggs, egg whites, or whey (protein-matched, macronutrient and energy matched). Outcomes: VAS soreness and strength recovery over 72 h recovery window, bio-markers of muscle damage (CK) and mechanisms (post-prandial amino acid profiles and fatty acid profiles in a subset of participants).

Interventions

The three acute dietary interventions are as follows: • Whole eggs (WE): e.g., 3 whole eggs (volume will be standardised across participants to provide 18 g protein from eggs), prepared as a standardised omelette with vegetables, toast and 300ml of water and no added fat. • Egg whites (EW): egg-white equivalent to match protein target (e.g., ~250–300 mL liquid whites standardised to provide 18 g of protein), prepared in the same recipe format as above with vegetable oil added to match fat conten

The three acute dietary interventions are as follows: • Whole eggs (WE): e.g., 3 whole eggs (volume will be standardised across participants to provide 18 g protein from eggs), prepared as a standardised omelette with vegetables, toast and 300ml of water and no added fat. • Egg whites (EW): egg-white equivalent to match protein target (e.g., ~250–300 mL liquid whites standardised to provide 18 g of protein), prepared in the same recipe format as above with vegetable oil added to match fat content above. • Whey protein (WP): flavoured shake providing the same protein dose along with toast as above with water provided to match fluid intake above and vegetable oil added to match fat across conditions. As well as the treatment arms described here, participants will also complete a standardised exercise protocol as the Exercise Induced Muscle Damage (EIMD) intervention. This exercise is comprised of 30 sets of 10 reps of maximal eccentric leg extensions on an isokinetic dynamometer. Intensity is defined as maximal on each repetition. This exercise intervention is to be administered and supervised by members of the research team with extensive prior experience in similar exercise interventions (Dr Urwin, Dr Convit, Dr Hamilton). The dietary interventions will commence immediately following the conclusion of the EIMD, and all food is to be consumed within a 30 minute period. The 30 minute ingestion period also applies to the subsequent days within each treatment (i.e. the three days following EIMD). The dietary intervention is to be designed by a dietitian within our team (Dr Convit), and delivered by members of the research team with extensive experience in acute feeding studies (Dr Convit, Dr Urwin). Adherence to the first meal is confirmed by the research team. Adherence to subsequent days is confirmed by the participants. Each trial is separated by a 14 day washout period. With limb alternation, washout between limb repeats is equal to a minimum of 31 days (two 14 days washouts, plus the 3 day intervention on the alternate limb). For a sub set of participants (n = 10, equal numbers M and F), we will we will perform amino-acid profiling (liquid chromatography-tandem mass spectrometry; LC-MS/MS) and fatty-acid profiling (GC-MS) at baseline (pre-meal) and every 10-20mins for the 3 h post-meal window during each period. This involves collection of venous blood samples via cannulation at the prescribed intervals, during which time participants stay seated and complete sedentary activities only (such as reading, watching TV). Cannulation and sample collection is to be completed by phlebotomy trained and experienced members of the research team (Dr Urwin, Dr Convit). Venous blood samples collected will be centrifuged to collect plasma, which will be frozen for later analysis. This sub set of participants is selected as the first 5 male and the first 5 female participants to ensure adherence to the planned sample size.

Sponsors

Deakin University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy adults (18–30 y), mixed-sex, who are active (exercise at least 3 times/week for at least the previous 6 months but not strength trained) and can attend all lab sessions and willing to limit egg consumption to only the eggs provided to them during the trial.

Exclusion criteria

Egg allergy/intolerance; inability to suspend egg consumption or recovery-affecting supplements (e.g., creatine, high-dose omega-3) during the study; regular NSAID/analgesic use that cannot be paused; significant musculoskeletal, cardiovascular, or metabolic disease; shift work; pregnancy/lactation; current high-dose protein supplementation (>40 g/day from powders) unwilling to standardise.

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 3, 2026